ACS omega

Germacrone may improve diabetic kidney disease by boosting cell cleanup and reducing inflammation through TFEB activation

Updated

Abstract

Essence

Germacrone improved markers by activating - signaling, promoting , and reducing NLRP3 inflammation.

Evidence

Preclinical in vitro and in vivo experiments screened sesquiterpenoids and tested germacrone effects on TFEB activation, renal function, renal pathology, autophagy, and NLRP3 inflammasome clearance.

Caveat

The abstract does not describe human clinical testing, so germacrone remains a mechanistic preclinical intervention rather than an established DKD treatment.

Simplified

Key numbers

significant
Decrease in Serum Creatinine
Measured levels of serum creatinine in mice.
significant
Decrease in Blood Urea Nitrogen
Blood urea nitrogen levels assessed in mice.
significant
Decrease in Expression
protein levels measured in renal tissues.

Full Text

We can’t show the full text here under this license.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free